Login / Signup

Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer.

Silvia CantaraEugenio BertelliRossella OcchiniMarì RegoliLucia BrilliFurio PaciniMaria Grazia CastagnaPaolo Toti
Published in: Endocrine (2019)
These data suggest that immunotherapy may be a promising treatment specific for ATC suggesting the need to start with clinical TRIALs.
Keyphrases
  • clinical trial
  • electronic health record
  • randomized controlled trial
  • big data
  • human health
  • risk assessment
  • machine learning
  • phase ii
  • deep learning
  • study protocol
  • data analysis